qtr-four earnings per share $num-one.
sees fy year-seven revenue $num-one billion to $1.0 billion.
qtr-four earnings per share $num-one.
reaffirms its previously issued three-year compound annual growth rate target for revenue growth rate of num-one% to num-two% for year-six through year-eight.
qtr-four revenue rose num-two percent to $num-one billion.
qtr-four revenue rose num-one percent to $num-two billion.
compname reports qtr-four other operating income of $num-one million.
qtr-three adjusted earnings per share $num-one excluding items.
qtr-four revenue rose num-one%.
qtr-four revenue rose num-one percent to $num-two million.
qtr-four earnings per share $num-two.
qtr-four revenue per patient day $num-two.
compname reports qtr-four other operating income of $num-one million.
compname reports qtr-four adjusted ebitda of $num-two million.
qtr-four interest income $num-one per share.
sees capital expenditures for fiscal year-six in range of $num-one million to $2.0 million.
